2 ms·
> The profit motive would clearly prioritize finding an expensive medication that must be taken regularly and indefinitely. The idea that pharmaceutical compan
by PragmaticPulp 6y ago
> The profit motive would clearly prioritize finding an expensive medication that must be taken regularly and indefinitely.
The idea that pharmaceutical companies are deliberately avoiding one-time treatments is a myth.
If you assume profit is the ultimate motive, there's nothing stopping a pharmaceutical company from charging $10,000 for a long-lasting depression treatment.
It's not like pharmaceutical companies are going to stumble upon a perfect treatment and then decline to patent it.
Also, patents don't last forever. Common SSRI anti-depressants are available for $4-5/month.